Peter Hersey

Professor Peter Hersey is a leading academic in Melanoma Biology at the University of Sydney's Northern Clinical School, affiliated with the Faculty of Medicine and Health. He holds roles as Research Director at the Newcastle Melanoma Unit and Consultant Immunologist to the Melanoma Institute Australia. His expertise spans tumor immunology, melanoma clinical trials, and resistance to apoptosis therapies. He completed his medical degree at the University of Adelaide and a D.Phil in tumor immunology at the University of Oxford.

Hersey's research focuses on immunological aspects of melanoma, including adjuvant immunotherapy trials and dendritic cell vaccines. He emphasizes overcoming resistance to cell death pathways as critical for melanoma treatment advances. He leads an NHMRC Program Grant on melanoma studies and contributes to editorial boards of major journals.

His recent articles explore sex-based differences in melanoma survival, epigenetic therapies (e.g., BET/CDK9 inhibitors), and immune checkpoint inhibitors. Key themes include immunotherapy resistance, combination therapies, and genetic factors influencing cancer outcomes.

• Grants: National Health and Medical Research Council (NHMRC) Program Grant
• Advising: Mentors research teams across melanoma immunology and clinical trials
• Labs/Teams: Leads research at Newcastle Melanoma Unit and collaborates with the Melanoma Institute Australia